Newsroom

Sorted by: Latest
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 10.12.2025 FEUD IE00BF2FL590 370,743.00 EUR 18,438,787.94 49.735  ...
-

Spark Reply et Concept Reply mettent en avant la recharge optimisée en CO₂ en collaboration avec BMW

TURIN, Italie--(BUSINESS WIRE)--Spark Reply, spécialiste de la conception et de l’expérience utilisateur, et Concept Reply, expert en technologies IoT et IA au sein de Reply Group, ont développé une application intelligente pour le groupe BMW dans le cadre d’un projet de recherche qui encourage activement les conducteurs de véhicules électriques à adopter des habitudes de recharge à faible émission de carbone. La fonction « COOL » de l’application de prototypage BMW « 360° Mobility » analyse le...
-

DigitalChalk to Be Featured on Now We Know! with Steve Guttenberg and CNBC

ASHEVILLE, N.C.--(BUSINESS WIRE)--DigitalChalk to appear on Now We Know! on CNBC to highlight LMS innovation and real results in workforce training, compliance and skills growth....
-

Toshiba Brings Innovative New Mobile Solutions to Retailers like Away

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Toshiba’s new TCx® M7 and TCx® M11 mobile solutions empower retailers with connected technology to enhance experiences across all touchpoints....
-

Prilenia and Ferrer Announce FDA Clearance to Start the “PREVAiLS” Pivotal Phase 3 Study with Pridopidine in ALS

NAARDEN, The Netherlands & WALTHAM, Mass. & BARCELONA, Spain--(BUSINESS WIRE)--Prilenia Therapeutics B.V. and Ferrer today announced that the US Food and Drug Administration (FDA) has cleared the start of the pivotal, 500-patient, randomized, placebo-controlled Phase 3 study of pridopidine in participants with rapidly progressive amyotrophic lateral sclerosis (ALS) early in their disease course. Recruitment is planned to begin at the first US clinical trial sites in early 2026, with sites in Eu...
-

Stem Cell Therapy Global Market Intelligence Report 20250 Featuring Smith+Nephew, Medipost, Anterogen, NuVasive, Pharmaceuticals, Orthofix - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Technology Landscape, Trends and Opportunities in Stem Cell Therapy Market" has been added to ResearchAndMarkets.com's offering. The stem cell therapy market has recently experienced a significant shift from traditional methods to advanced technologies that enhance efficiency, personalization, and regulatory compliance. This evolution includes advancements in techniques such as moving from allogeneic to autologous stem cell therapy and integrating leading-edge tool...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 10.12.2025 CPQ IE00BFD2H405 8,875,002.00 USD 505,721,706.47 56.983  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 10.12.2025 FKUD IE00BD9N0445 118,031.00 GBP 3,184,705.75 26.982  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 10.12.2025 FDNU IE00BG0SSC32 2,425,002.00 USD 91,570,180.17 37.761  ...
-

ALT5 Sigma Corporation Provides Strategic Overview of $WLFI Treasury Strategy, USD1 Stablecoin Utility and Its Relevance to the Company’s Future Payment Infrastructure

LAS VEGAS--(BUSINESS WIRE)--ALT5 Sigma Corporation (the “Company,” “our” or “ALT5”) (NASDAQ: ALTS) (FRA:5AR1), a fintech company with established global payments, trading, and settlement infrastructure, today released a strategic overview on the USD1 stablecoin, its relevance to ALT5’s core long-term payments technology product, and the anticipated benefits to the Company’s $WLFI Treasury Strategy. Why USD1 Matters to ALT5 ALT5 is a leading holder of $WLFI, the governance token of the World Lib...